Evidence map›Paper›PMID 24750052›Full record

ArticleRegenerative medicine2014

Stem cell-based therapies for multiple sclerosis: recent advances in animal models and human clinical trials.

Sarah E Lutz, Justin Lengfeld, Dritan Agalliu

Abstract readEditorial
In one paragraph

Article in Regenerative medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Induced Stem Cells as a Novel Multiple Sclerosis Therapy.Current stem cell research & therapy · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sarah E LutzDepartment of Developmental & Cell Biology, University of California, Irvine, CA 92697, USA.
Justin Lengfeld
Dritan Agalliu

Funding

CNS angiogenesis and blood-brain barrier regulation by the Wnt inhibitor Apcdd1.R01HL116995 · NHLBI · UNIVERSITY OF CALIFORNIA-IRVINE · PI AGALLIU, DRITAN · 2013 to 2017
$1.9M
NHLBI NIH HHS 1R01 HL116995-01NHLBI NIH HHS R01 HL116995
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Clinical Trials as TopicDisease Models, AnimalAnimalsBlood-Brain BarrierHumansMultiple SclerosisMyelin SheathStem Cell Transplantation

Identifiers

PMID24750052
PMCPMC4832963

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.